Connection
Daniel Matlock to Desensitization, Immunologic
This is a "connection" page, showing publications Daniel Matlock has written about Desensitization, Immunologic.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
1.239 |
|
|
|
-
Greenhawt M, Shaker M, Winders T, Bukstein DA, Davis RS, Oppenheimer J, Fleischer DM, Kim E, Chan ES, Stukus DR, Matlock D. Development and acceptability of a shared decision-making tool for commercial peanut allergy therapies. Ann Allergy Asthma Immunol. 2020 07; 125(1):90-96.
Score: 0.654
-
Greenhawt M, Marsh R, Gilbert H, Sicherer S, DunnGalvin A, Matlock D. Understanding caregiver goals, benefits, and acceptable risks of peanut allergy therapies. Ann Allergy Asthma Immunol. 2018 11; 121(5):575-579.
Score: 0.584